Download PDF
Fortschr Neurol Psychiatr 2004; 72(10): 564-573
DOI: 10.1055/s-2004-818530
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Angst im Alter - Epidemiologie, Diagnostik und therapeutische Optionen

Anxiety in Elderly People - Epidemiology, Diagnostic Features and Therapeutic OptionsR.  J.  Boerner1
  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie im Klinikum Innenstadt der Ludwig-Maximilians-Universität München (Direktor: Prof. Dr. med. Hans-Jürgen Möller)
Further Information

Publication History

Publication Date:
27 September 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Angsterkrankungen im höheren Lebensalter stellen mit einer Prävalenz von annähernd 10 % eine wichtige psychiatrische Störung dieser Altersgruppe dar, die bisher in Schweregrad und Bedeutung völlig unterschätzt wurde. Die Problematik der Nichterkennung und Nichtbehandlung im klinischen Alltag ist erheblich. Möglicherweise spielt eine Rolle, dass pathologische Altersformen vermutlich nicht leicht von normalpsychologischen Phänomenen abzugrenzen sind und bei der Definition soziokulturelle Wertmaßstäbe eine wichtige Rolle spielen. Die Komorbidität von Angsterkrankungen untereinander mit weiteren psychiatrischen Störungen wie Depressionen ist beträchtlich. Die psychosozialen Folgen sind für die Betroffenen erheblich. Studien zeigen, dass neuere Antidepressiva wie Venlafaxin oder Verfahren der Verhaltenstherapie wirksam eingesetzt werden können.

Abstract

Anxiety disorders in older age represent with a prevalence rate of 10 % an important psychiatric problem, which has not been adequately recognised and diagnosed. This can be explained from the idea, that pathologic anxiety was evaluated as a normal reaction by elderly people. The actual classification of anxiety disorders with ICD-10 or DSM-IV was not sufficient and should be complemented by a syndromanal approach. The comorbidity of anxiety disorders with other psychiatric disorders, e. g. depression, and also with somatic diseases was high. The psychosocial consequences are important. Psychopharmacological and psychotherapeutic interventions have been proven in some studies and should be practised more in the future.

Literatur

  • 1 Beekman A TF, Bremmer M A, Dorly J H. et al . Anxiety disorders in later life: a report from the longitudinal aging study Amsterdam.  Int J Geriatr Psychiat. 1998;  13 717-726
    CrossrefPubMedGoogle Scholar
  • 2 Boerner R J. Das Angstbasissyndrom. Ein neues Konzept zur Diagnostik von Angststörungen.  Extr psychiatrica. 2001;  3 16-20
    PubMedGoogle Scholar
  • 3 Basha I, Mukerji V, Langevin P. et al . Atypical angina in patients with coronary artery disease suggests panic disorder.  Int J Psychiatry Med. 1989;  19 341-346
    PubMedGoogle Scholar
  • 4 Lindesay J. Phobic disorders in the elderly.  Br J Psychiatry. 1991;  155 317-329
    PubMedGoogle Scholar
  • 5 Knauper B, Wittchen H U. Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews.  J Psychiatr Res. 1994;  28 147-164
    CrossrefPubMedGoogle Scholar
  • 6 Regier D A, Boyd J H, Burke J D. et al . One month prevalence of mental disorders in the United States.  Arch Gen Psychiatr. 1988;  45 977-986
    PubMedGoogle Scholar
  • 7 Bland R C, Newman C, Orn H. Prevalence of psychiatric disorders in the elderly in Edmonton.  Acta Psychiatr Scand. 1988;  77 57-63
    PubMedGoogle Scholar
  • 8 Deeg D JH, Knipscheer D PM, Tilburg W van. Autonomy and well-being in the aging population. Concepts and design of the longitudinal aging study Amsterdam. (Netherlands Inst Geront) NIG Trend Studies No.7 1993
    Google Scholar
  • 9 Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale.  Acta psychiatr Scand. 1983;  67 361-370
    CrossrefPubMedGoogle Scholar
  • 10 Radloff L S. The CES-D scale: A self-report scale for research in the general population.  Appl Psychol Meas. 1977;  1 385-401
    CrossrefPubMedGoogle Scholar
  • 11 Robbins L, Hlezer J E, Croughan J. et al . National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics and validity.  Arch Gen Psychiat. 1981;  38 381-389
    PubMedGoogle Scholar
  • 12 Kathol R G, Turner R, Delahunt J. Depression and anxiety associated with hyperthyreodism. Response to antithyroid therapy.  Psychosom. 1986;  27 501-505
    PubMedGoogle Scholar
  • 13 Lustman P J, Griffith L S, Clouse R E. et al . Psychiatric illness in diabetes mellitus: Relationship to symptoms and glucose control.  J Nerv Ment Disord. 1986;  174 736-742
    PubMedGoogle Scholar
  • 14 Popkin M K, Callies A L, Lentz R D. et al . Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus.  Arch Gen Psychiatry. 1988;  45 64-68
    PubMedGoogle Scholar
  • 15 Beitman B D, Kushner M, Lamberti J W. et al . Panic disorder without fear in patients with angiographically normal coronary arteries.  J Nerv Ment Dis. 1990;  178 307-312
    PubMedGoogle Scholar
  • 16 Karajgi B, Rifkin A, Doddi S. et al . The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease.  Am J Psychiatr. 1990;  147 200-201
    PubMedGoogle Scholar
  • 17 Yellowless P M, Alpersa J H, Bowden J J. et al . Psychiatric morbidity in subjects with chronic airflow obstruction.  Med J Aust. 1987;  146 305-307
    PubMedGoogle Scholar
  • 18 Kane F J, Strohlein J, Harper J G. Nonulcer dyspepsia associated with psychiatric disorder.  South Med J. 1993;  86 641-646
    PubMedGoogle Scholar
  • 19 Stein M B, Heuser I J, Juncos J L. et al . Anxiety disorders in patients with Parkinson's disease.  Am J Psychiatry. 1990;  147 217-220
    PubMedGoogle Scholar
  • 20 Lenze E J, Mulsant B H, Shear M K. Comorbidity of depression and anxiety disorders in later life.  Depression and Anxiety. 2001;  14 86-93
    CrossrefPubMedGoogle Scholar
  • 21 Devanand D P. Comorbid psychiatric disorders in late life depression.  Biol Psychiatry. 2002;  51 236-242
    PubMedGoogle Scholar
  • 22 Mulsant B H, Reynolds C F, Shear M K. Comorbid anxiety disorders in late-life depression.  Anxiety. 1996;  2 242-247
    CrossrefPubMedGoogle Scholar
  • 23 Beekman A TF, Beurs E de, Balkom A JLM van. et al . Anxiety and depression in later life: Co-occurence and communality of risk factors.  Am J Psychiatry. 2000;  157 89-95
    PubMedGoogle Scholar
  • 24 Palmer B W, Jeste D V, Sheikh J I. Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment.  J Affect Disord .. 1997;  46 183-190
    CrossrefPubMedGoogle Scholar
  • 25 Balkom A JLM Van, Beekman A TF, Beurs E de. et al . Comorbidity of the anxiety disorder in a community-based older population in The Netherlands.  Acta psychiatr scand. 2000;  101 37-45
    PubMedGoogle Scholar
  • 26 Beurs E De, Beekman A TF, Balkom A JLM van. et al . Consequences of anxiety in older persons: its effect on disability, well-being and use of health services.  Psychol Med. 1999;  29 583-593
    CrossrefPubMedGoogle Scholar
  • 27 Flint A J. Epidemiology and comorbidity of anxiety disorders in the elderly.  Am J Psychiat. 1994;  151 640-649
    PubMedGoogle Scholar
  • 28 Sambamoorthi U, Olfson M, Walkup J T. et al . Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.  Med Care. 2003;  41 (1) 180-194
    CrossrefPubMedGoogle Scholar
  • 29 Butler R, Collins E, Katona C. et al . How do general practitioners select antidepressants for depressed elderly people?.  Int J Geriatr Psychiatr. 2000;  15 610-613
    PubMedGoogle Scholar
  • 30 Boerner R J. Spezielle Therapiestrategien. Antidepressiva bei nicht depressiven Erkrankungen. Angststörungen. In: Riderer P, Laux E, Poldinger W (Hg). Neuro-Psychopharmaka Bd 3: Antidepressiva, Pharmaprophylaktika und Stimmungsstabilisatoren. Wien, New York: Springer 2. Aufl 2002: 705-731
    Google Scholar
  • 31 Katona C. Managing depression and anxiety in the elderly patient.  European Neuropsychopharmacol. 2000;  10 (Suppl 4) 427-432
    PubMedGoogle Scholar
  • 32 Doraiswamy P M. Contemporary management of comorbid anxiety and depression in geriatric patients.  J Clin Psychiatry. 2001;  62 (Suppl 12) 30-35
    CrossrefPubMedGoogle Scholar
  • 33 Lenze E J, Mulsant B H, Shear M K. et al . Anxiety symptoms in elderly patients with depression: what is the best approach for treatment?.  Drugs Aging. 2002;  19 (10) 753-760
    PubMedGoogle Scholar
  • 34 Montgomery S A, Judge R. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.  Acta Psychiatr Scand. 2000;  403 (Suppl) 9-16
    PubMedGoogle Scholar
  • 35 Goldberg R J. Antidepressants use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.  Drugs Aging. 1997;  11 (2) 119-131
    CrossrefPubMedGoogle Scholar
  • 36 Schatzberg A F, Kremer C, Rodrigues H E. et al . Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.  Am J Geriatr Psychiatry. 2002;  10 (5) 541-550
    PubMedGoogle Scholar
  • 37 Katz I R, Reynolds C F III, Alexopoulos G S. et al . Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.  J Am Geriatr Soc. 2002;  50, 1 18
    CrossrefPubMedGoogle Scholar
  • 38 Boerner R J, Garziella M, Achenbach V. Hydroxyzin in der Therapie der Generalisierten Angststörung des höheren Lebensalters. Paper submitted. Int J Geriatr Psychiat 2004
    Google Scholar
  • 39 Sonnenberg C M, Beekman A TF, Dorly J H. et al . Drug treatment in depressed elderly in the Dutch community.  Int J Geriatr Psychiatry. 2003;  18 99-104
    PubMedGoogle Scholar
  • 40 Stanley M A, Beck J G, Witt Glassco J de. Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches.  Behavior Therapy. 1996;  27 565-581
    PubMedGoogle Scholar
  • 41 Barrowclough C, King P, Colville J. et al . A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults.  J Consult Clin Psychol.. 2001;  69 756-762
    CrossrefPubMedGoogle Scholar
  • 42 Stanley M A, Hopko D R, Diefenbach G J. et al . Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: preliminary findings.  Am J Geriatric Psychiatry. 2003;  11 (a) 92-96
    PubMedGoogle Scholar
  • 43 Stanley M A, Beck J G, Novy E M. et al . Cognitive-behavioral treatment of late-life generalized anxiety disorder.  J Consult Clin Psychol. 2003;  Apr 71 (b) 309-319
    CrossrefPubMedGoogle Scholar
  • 44 Wetherell J L, Gatz M, Craske M G. Treatment for generalized anxiety disorder in older adults. J Consult Clin Psychol 2003; in press
    Google Scholar
  • 45 Mohlman J, Gorenstein E E, Kleber M. et al . Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder. Two pilot investigations.  Am J Geriatr Psychiatry. 2003;  11 24-32
    PubMedGoogle Scholar
  • 46 Areán P. Cognitive-behavioral therapy with older adults.  The Behavior Therapist. 1993;  16 236-239
    PubMedGoogle Scholar
  • 47 Gorenstein E E, Papp L A, Kleber M S. Cognitive-behavioral treatment of anxiety in later life.  Cog Behav Practice. 1999;  6 305-319
    PubMedGoogle Scholar
  • 48 Gum A, Arean P A. Current status of psychotherapy for mental disorders in the elderly.  Current Psychiatr Rep 2004. Feb ;  6 (1) 32-38
    PubMedGoogle Scholar

Dr. Dr. Dipl.-Psych. Reinhard J. Boerner

Klinik für Psychiatrie und Psychotherapie · Christliches Krankenhaus Quakenbrück e. V.

Goethestr. 10

49610 Quakenbrück

Email: r.boerner@christliches-krankenhaus-ev.de